Natural Hair Care Under the Microscope: A Scientific Investigation Into Shared Ingredients, Scalp Reactions, Hair Breakage, and Hair Loss
An evidence-based research article for the natural-hair community • Research reviewed October 2024-2026
Natural and organic hair-care products have become popular among consumers seeking healthier hair, stronger curls, moisture retention, and improved scalp health. However, the terms natural, organic, botanical, sulfate-free, and clean do not, by themselves, establish the safety or effectiveness of a finished hair-care formula.
This investigation examines the potential similarities among products from Kaleidoscope Hair Products, Mielle Organics, Bask & Lather, WEN Cosmetics, DevaCurl, SheaMoisture, Camille Rose, TGIN, As I Am, Aunt Jackie’s, and Carol’s Daughter. Particular attention is given to ingredients shared across formulas, the scientific evidence concerning contact dermatitis and hair-fiber damage, and the distinction between cosmetic breakage and hair loss originating at the follicle.
The investigation also examines a significant regulatory research project conducted by the U.S. Food and Drug Administration (FDA) involving WEN Sweet Almond Mint Cleansing Conditioner and DevaCurl Low-Poo Delight Cleanser. The FDA study found abnormal hair-growth cycles in mice after prolonged exposure to these products and evaluated five ingredients present in both formulas. However, the study did not establish that these ingredients or products cause alopecia in humans.
The central question is not whether every natural hair product is harmful. It is whether products marketed toward similar consumers share particular ingredients, whether those ingredients have documented safety concerns under specific conditions, and what evidence is necessary before attributing hair loss to a product.
The primary conclusion is that ingredient overlap is a legitimate scientific question, but overlap alone is not proof of toxicity or causation. A responsible investigation must examine the finished formula, exposure, concentration, individual susceptibility, product history, and quality of the evidence.
1. Introduction: What does “natural” actually mean?
The natural-hair market includes shampoos, co-washes, cleansing conditioners, deep conditioners, scalp oils, leave-in treatments, and products marketed for growth or strengthening. Many formulas combine conventional cleansing agents and preservatives with plant oils, botanical extracts, proteins, humectants, and fragrance ingredients.
Consumers may interpret a product’s natural positioning as an indication that its ingredients are inherently safe. Conversely, viral discussions about hair loss can lead consumers to interpret unfamiliar chemical names as evidence that a product is toxic.
Neither conclusion is scientifically justified without further analysis.
Everything in a cosmetic formula is composed of chemicals, including water, coconut oil, rosemary extract, and synthetic preservatives. The relevant safety questions concern the identity of each ingredient, its concentration, its purity, how it is formulated, how it is used, and whether it causes adverse effects under realistic conditions.
The peer-reviewed review Hair Cosmetics: An Overview, published in the International Journal of Trichology in 2015, explains that shampoos contain multiple functional categories of ingredients, including cleansing agents, stabilizers, conditioning agents, and ingredients intended for specific hair or scalp concerns. The review also describes how inappropriate cleansing, grooming, and chemical treatments can contribute to hair-fiber damage.
This distinction is especially important when evaluating textured hair. Curly and tightly coiled hair can be vulnerable to tangling, friction, and mechanical breakage. A person who notices less hair length, increased shedding, or thinning around the hairline may be experiencing different problems that require different explanations.
How Poor Scalp Practices May Contribute to Inflammation and Hair Loss
1. The scalp is a protective barrier, not just a surface for products
The outermost layer of the skin, called the stratum corneum, is a protective barrier made of flattened skin cells held together by lipids. It helps limit water loss and reduces the penetration of irritants, allergens, and microorganisms.
A healthy scalp also supports a complex community of microorganisms, including bacteria and fungi that normally live on the skin.
When this barrier is disrupted, the skin may become more susceptible to irritation.
Inflammation can also occur because of an underlying skin condition, allergic contact dermatitis, friction, scratching, or excessive exposure to irritating products.
Importantly, the barrier does not automatically become damaged because someone uses oil or cream. The outcome depends on the ingredients, formulation, frequency of use, cleansing practices, existing skin conditions, and individual susceptibility.
2. Leaving the scalp wet for prolonged periods
Water itself does not cause hair loss. Washing your hair is not inherently harmful, and allowing hair to air-dry is not automatically a problem.
The concern is prolonged dampness combined with other conditions, such as occlusion, inadequate drying, pre-existing inflammation, or a susceptible scalp.
Repeated or prolonged wetting can alter the hydration of the stratum corneum. Excessive hydration can make the outer skin layer softer and more susceptible to friction and mechanical damage. In clinical settings, prolonged moisture exposure and occlusion are recognized contributors to skin maceration.
What might happen in a scalp-care context?
Damp skin may be more vulnerable to friction from tight hairstyles, scratching, or aggressive manipulation.
A persistently moist environment under a tightly covered scalp may contribute to discomfort and may aggravate some existing skin conditions.
If a person already has dermatitis, broken skin, or an infection, additional irritation and scratching can worsen the problem.
Wet hair fibers are also more vulnerable to certain forms of mechanical damage, especially when aggressively rubbed, detangled, or pulled.
However, there is an important limitation: there is not strong clinical evidence that simply sleeping with damp hair directly causes follicular hair loss. The concern is the surrounding combination of prolonged moisture, friction, occlusion, and scalp health—not water alone.
3. Packing the scalp with oils, butters, and creams
This is where the discussion becomes particularly relevant to natural-hair routines.
Many people layer scalp oils, heavy butters, leave-in conditioners, styling creams, growth serums, and edge-control products, sometimes applying several products without thoroughly cleansing the scalp between applications.
More product does not automatically mean healthier hair.
Oils and butters can be useful for reducing friction, improving manageability, and conditioning the hair shaft. The potential problem is excessive layering, poor product tolerance, inadequate cleansing, or applying products that aggravate an existing scalp condition.
Possible consequences include:
Follicular bumps: Occlusive products can contribute to certain forms of folliculitis in susceptible individuals.
Hairline breakouts: The American Academy of Dermatology describes acne cosmetica, in which hair products contribute to clogged pores and bumps around the hairline and forehead.
Irritation or allergy: Fragrances, preservatives, surfactants, and botanical ingredients can trigger reactions in susceptible people.
Residue and tangling: Heavy layering may make some hair harder to cleanse and detangle, increasing mechanical stress during grooming.
Worsening of existing symptoms: If the scalp is already inflamed, repeated application of irritating products or aggressive cleansing may aggravate discomfort and scratching.
There is an important scientific distinction here: oils and butters do not automatically suffocate hair follicles, and oil buildup does not inevitably cause infection or baldness. The relevant issue is whether a particular routine contributes to occlusion, irritation, inflammation, or mechanical damage.
4. How a compromised scalp may react differently to ingredients
Think of the scalp as a protective barrier. When that barrier is healthy, it helps limit the penetration of irritating substances. When the skin is inflamed, abraded, or affected by dermatitis, the response to products may change.
However, an irritated scalp does not automatically react badly to every ingredient, and a healthy scalp does not guarantee that an ingredient cannot cause an allergic reaction.
Two mechanisms are particularly important:
Irritant contact dermatitis: A substance directly irritates the skin. The effect can depend on its concentration, contact time, frequency of exposure, and the condition of the skin.
Allergic contact dermatitis: The immune system reacts to a particular allergen after sensitization. Even an ingredient tolerated previously may trigger a reaction after sensitization develops.
A 2022 systematic review by Pham and colleagues examined 99 studies involving 3,185 patients and identified multiple categories of scalp and hair products associated with allergic contact dermatitis. Reported symptoms included itching, burning, and eczematous skin changes. The authors emphasized the importance of identifying the specific allergen rather than assuming that all products cause the same reaction.
This is why two people can use the same shampoo and have very different experiences. One person may tolerate it without difficulty; another may develop itching, burning, scaling, or inflammation.
It is also why a product that was previously tolerated may need to be reconsidered if new symptoms develop.
1. Repeated product layering or irritating exposure
Oils, butters, creams, fragrances, preservatives, or unsuitable cleansing practices
2. Possible scalp irritation or occlusion
In susceptible individuals, this may contribute to itching, bumps, or dermatitis
3. Scratching, friction, and further irritation
Repeated mechanical trauma can worsen symptoms and damage hair fibers
4. Possible hair breakage or shedding
The outcome depends on the cause, severity, duration, and individual susceptibility
This is a possible pathway, not an inevitable sequence. Many people use oils and styling creams without developing scalp inflammation. The goal is to identify the routines and ingredients that may be contributing to problems in particular individuals.
5. Can scalp inflammation actually make hair fall out?
Yes, in some circumstances but the mechanism and strength of evidence matter.
A peer-reviewed study published in Archives of Dermatology in 2001 investigated acute telogen effluvium following allergic contact dermatitis of the scalp. Of the seven women who completed the study, four experienced increased hair shedding two to four months after the dermatitis episode. The researchers concluded that acute scalp contact dermatitis should be considered a possible cause of telogen effluvium.
Telogen effluvium is a condition in which more hairs than usual enter the shedding phase of the hair-growth cycle. It can follow different physical or physiological stressors, and it is not synonymous with permanent baldness.
That study provides evidence that significant scalp inflammation can be followed by increased hair shedding. It does not establish that ordinary product buildup or every heavy oiling routine causes telogen effluvium.
Other inflammatory scalp conditions can also require medical evaluation. Persistent folliculitis, severe dermatitis, and certain inflammatory disorders may threaten hair growth, while some scarring conditions can cause permanent follicular damage.
This makes it important not to dismiss persistent burning, pain, crusting, pustules, or progressive thinning as merely a reaction to a product.
6. The cycle worth investigating
7. What this means for your natural-hair ingredient investigation
The strongest scientific argument is not that natural-hair products are inherently dangerous. It is that ingredient safety cannot be assessed in isolation from the finished formula, how the product is used, and the condition of the scalp.
“Are We Caring for the Hair Shaft While Neglecting the Scalp?”
Whether products are intended for the scalp, hair shaft, or both.
Whether multiple leave-in products contain overlapping fragrances or potential allergens.
Whether people are experiencing itching, burning, bumps, flaking, or other symptoms.
Whether cleansing and drying routines are appropriate for their hair and scalp.
Whether the reported outcome is breakage, temporary shedding, or a diagnosed form of alopecia.
The key is to compare actual product labels and reported symptoms with peer-reviewed evidence, rather than assume that a shared ingredient or a particular routine proves causation.
The bottom line
A healthy scalp is part of a healthy-hair routine. Excessive product layering, unsuitable cleansing practices, prolonged moisture combined with occlusion, and repeated scratching or friction may contribute to scalp problems in some people. Certain forms of significant scalp inflammation can also be followed by increased hair shedding.
But oils, butters, creams, and wet hair are not inherently harmful. The concern is the complete routine, the condition of the skin, and the individual’s response.
If someone develops persistent scalp inflammation or progressive hair loss, they should stop using suspected irritating products and seek assessment from a dermatologist. A clinician may recommend patch testing when allergic contact dermatitis is suspected. Painful swelling, pus, crusting, or rapidly progressing hair loss warrants prompt medical evaluation.
The four questions every ingredient investigation should answer
Presence: Is the ingredient actually listed in the specific product being investigated?
Hazard: Can the ingredient cause a particular adverse effect under some conditions?
Exposure: Is the ingredient present at a concentration and exposure level relevant to that adverse effect?
Causation: Is there credible evidence that the ingredient or finished product caused the reported outcome?
An ingredient can have a documented hazard without posing the same level of risk in every formula. Likewise, a product may cause irritation in a susceptible individual without causing hair loss in the general population.
These are the distinctions that must guide the investigation of all 11 brands.
2. The WEN and DevaCurl investigation: The most important starting point
WEN Sweet Almond Mint Cleansing Conditioner
Historical product investigated by the FDA
WEN became a significant subject of concern after consumers reported hair loss, breakage, itching, and rashes associated with cleansing conditioners.
DevaCurl Low-Poo Delight Cleanser
Historical product investigated by the FDA
This product was also examined in the FDA’s research into possible associations between hair-cleansing products, their ingredients, and abnormal hair-growth cycles.
The FDA’s project, titled Studies on Hair Loss (Alopecia) Associated With Use of Cosmetic Hair Products and Ingredients in These Products, ran from August 2018 through August 2022. Its final report investigated potential biological effects associated with WEN and DevaCurl cleansing products and selected ingredients found in both formulas.
What did the research find?
The FDA reported that mice exposed to WEN Sweet Almond Mint Cleansing Conditioner or DevaCurl Low-Poo Delight Cleanser over a prolonged period displayed abnormal hair-growth cycles. The report also identified five ingredients shared by the two tested products that were investigated in laboratory experiments involving dermal papilla cells, which are cells involved in regulating hair-follicle biology.
Those five ingredients were:
Rosemary extract
Calendula extract
Methylchloroisothiazolinone
Methylisothiazolinone
Polysorbate 60
The researchers reported cytotoxic effects in dermal papilla cells for these ingredients under the experimental conditions used. Cytotoxicity means that cells experienced harmful effects; it does not automatically establish that an ingredient causes hair loss when used in a commercial product.
What did the research not prove?
The FDA explicitly stated that its investigation could not draw a firm connection between the products or ingredients and alopecia in humans. The findings are a reason for further investigation, not proof that the five ingredients cause baldness.
This distinction matters for three reasons.
First, experiments involving isolated cells do not reproduce every feature of a living human scalp. Second, findings in mice cannot automatically be translated into human outcomes. Third, a finished product contains multiple ingredients that interact within a formula, and the exposure in an experiment may differ from typical consumer use.
The FDA continues to advise consumers who experience suspected cosmetic adverse effects to stop using the product and report the event. Consumers experiencing hair loss should seek assessment from a qualified healthcare professional.
Why this case matters for the broader investigation
WEN and DevaCurl provide a concrete starting point because there is an identifiable regulatory research project examining two specific products and five shared ingredients.
That is substantially stronger evidence than a social-media post listing ingredients without verifying the formula or examining the research.
However, the findings cannot be generalized to every product sold by either brand, much less to all 11 brands in this investigation. Each product must be evaluated separately.
3. The ingredient similarities: What appears across multiple brands?
The next step is to compare published ingredient lists from specific products rather than assume every formula within a brand is identical.
The following comparison uses four identifiable products:
Mielle Organics Rosemary Mint Strengthening Shampoo.
Bask & Lather Strengthen Hair Shampoo.
DevaCurl Low-Poo Delight
SheaMoisture Coconut & Hibiscus Curl & Shine Shampoo.
Their currently published lists provide a useful starting point for identifying shared ingredients.
Table 1. Verified ingredient overlap in the selected products
Ingredient
Mielle Rosemary Mint Shampoo
Bask & Lather Strengthen Shampoo
DevaCurl Low-Poo Delight
SheaMoisture Curl & Shine Shampoo
Sources: the manufacturers’ published ingredient lists.
Interpretation: “Not listed” means absent from the specific published ingredient list examined. It does not mean the ingredient is absent from every product sold by that brand. Ingredient lists can differ by market, product version, and date.
Three patterns deserve closer attention.
Similarity
A: Cocamidopropyl betaine appears in multiple cleansing formulas
Cocamidopropyl betaine, commonly abbreviated CAPB, is an amphoteric surfactant.
Surfactants help lift oil, sebum, dirt, and product residue so they can be rinsed away.
CAPB is commonly used in combination with other cleansing agents to modify the cleansing and foaming properties of a formula.
It appears in the published formulas for Mielle Rosemary Mint Strengthening Shampoo, Bask & Lather Strengthen Hair Shampoo, and DevaCurl Low-Poo Delight.
What is the scientific concern?
CAPB has been investigated in the dermatology literature as a potential contact allergen. However, the evidence does not support describing it as a universally dangerous ingredient.
A 2011 peer-reviewed study by Schnuch and colleagues, published in Contact Dermatitis, analyzed patch-test data from 83,864 patients. Approximately 2.16% had positive patch-test reactions to CAPB, but the researchers concluded that the vast majority of positive reactions were probably false positives and that genuine allergic reactions were rare. They also discussed amidoamine, a manufacturing-related contaminant, as a possible explanation for some reactions attributed to CAPB.
An earlier 1997 study by Fowler and colleagues investigated ten people who had previously tested positive to CAPB. Seven developed dermatitis during product-use testing, and six of the nine participants who underwent subsequent testing reacted to amidoamine. This small, selected study supports the importance of distinguishing an ingredient itself from contaminants associated with its manufacture.
A larger retrospective analysis published in 2021 examined 38,775 patients who underwent patch testing through the North American Contact Dermatitis Group. Of these patients, 3,481 had positive reactions associated with hair-care products. Among the recorded positive reactions associated with hair-care products, CAPB accounted for 5.9%, while methylisothiazolinone and the methylchloroisothiazolinone/methylisothiazolinone combination also appeared among the more frequent allergens.
These numbers require careful interpretation: the patients were referred for patch testing, often because allergy was suspected. They do not represent the percentage of ordinary shampoo users who will develop an allergic reaction.
Scientific conclusion: CAPB is a shared cleansing ingredient worth tracking because allergic contact dermatitis is documented. Its presence alone does not demonstrate that a shampoo causes hair loss, nor does it establish that the three brands share the same risk.
Similarity B: Sodium C14-16 olefin sulfonate appears in Mielle and Bask & Lather
Both the published Mielle Rosemary Mint Strengthening Shampoo formula and Bask & Lather Strengthen Hair Shampoo contain sodium C14-16 olefin sulfonate.
This ingredient is an anionic surfactant used for cleansing. It should not automatically be equated with sodium lauryl sulfate or sodium laureth sulfate simply because the names contain similar terminology.
The important scientific question is how the complete formula performs under normal use, including its concentration, other surfactants, pH, conditioning agents, contact time, and how well it rinses away.
The peer-reviewed review Hair Cosmetics: An Overview describes how cleansing agents can remove oils and residues while also affecting the hair fiber’s surface properties. Formulation influences whether a shampoo cleans effectively while minimizing friction, tangling, and undesirable changes in manageability.
This is particularly relevant for dry, highly textured, chemically treated, or already damaged hair. A formula that cleans effectively for one person may leave another person’s hair feeling rougher or more difficult to detangle.
However, it would be inaccurate to conclude that sodium C14-16 olefin sulfonate causes baldness based on its presence in two shampoos.
Scientific conclusion: The overlap is verified in these two specific formulas. The appropriate question is whether their finished formulations differ in mildness, conditioning performance, and user tolerability not whether the shared surfactant is inherently toxic.
Similarity C: Rosemary and coconut ingredients appear across several natural-hair products
Mielle’s published Rosemary Mint Shampoo includes rosemary leaf oil and rosemary leaf extract, as well as coconut oil.
SheaMoisture’s published Coconut & Hibiscus Shampoo includes rosemary leaf oil and coconut oil.
Bask & Lather’s Strengthen Shampoo includes coconut oil and peppermint oil.
This is an important marketing similarity: brands often use familiar botanical ingredients to communicate moisture, strengthening, scalp care, and growth-related benefits.
But a botanical ingredient’s popularity does not establish that it stimulates human hair growth when included in a rinse-off shampoo.
Rosemary oil versus rosemary extract
These terms should not be treated as interchangeable.
Rosemary leaf oil is an essential oil containing volatile constituents.
Rosemary extract can refer to preparations obtained using different extraction methods and may have a different chemical composition.
The safety and biological activity of a preparation depend on its composition, concentration, and use.
The FDA’s WEN–DevaCurl research evaluated rosemary extract among five shared ingredients. The current published DevaCurl Low-Poo Delight ingredient list, however, does not list rosemary extract. The current Mielle and SheaMoisture lists identify rosemary oil and, in Mielle’s case, rosemary leaf extract.
This distinction matters: finding rosemary oil in a modern shampoo does not prove that the formula contains the same rosemary preparation used in the FDA’s historical experiments.
Does coconut oil cause hair loss?
The presence of coconut oil is not evidence that a product causes alopecia. Coconut oil is widely used as a conditioning ingredient, and the effects of a finished product depend on its full formulation and use.
The Hair Cosmetics: An Overview review discusses the roles of oils and conditioning ingredients in hair-fiber care. Such ingredients may affect lubrication, manageability, and friction. These properties are separate from evidence of effects on the biological hair-growth cycle.
Scientific conclusion: Botanical ingredients deserve the same evidence-based evaluation as synthetic ingredients. Neither “natural” nor “chemical” is a scientifically sufficient safety classification.
Similarity D: Preservatives appear in products that contain substantial amounts of water
Water-based shampoos and conditioners require suitable preservation to limit microbial contamination during manufacture, storage, and use.
The published formulas examined here contain different preservation systems. For example, Mielle and Bask & Lather list phenoxyethanol, while DevaCurl lists phenoxyethanol alongside other ingredients, including sodium benzoate and potassium sorbate.
Preservatives should not be treated as interchangeable simply because they serve a similar purpose.
The methylisothiazolinone and methylchloroisothiazolinone preservatives are particularly relevant to contact-allergy research.
A 2015 randomized, blinded repeated-open-application study examined methylisothiazolinone in rinse-off products among people with known MI allergy and controls. The study demonstrated why exposure through rinse-off products can matter for already sensitized individuals.
But the presence of phenoxyethanol in a shampoo does not establish that the product contains MI or MCI. Nor does the presence of any preservative, by itself, establish that a formula causes hair loss.
Scientific conclusion: Preservation systems should be evaluated ingredient by ingredient, taking account of the formula, concentration, exposure, and evidence of specific adverse effects. A preservative’s function is not evidence of toxicity.
4. The five ingredients in the FDA investigation: A closer scientific analysis
These five ingredients deserve a separate discussion because they were specifically investigated in the WEN–DevaCurl research. The evidence is not equally strong for every possible adverse effect, and the FDA’s findings should not be misrepresented as proof of human hair loss.
Table 2. What the evidence actually supports
Ingredient
Scientific issue to investigate
What cannot be concluded from its presence alone
Rosemary extract
Biological effects in the FDA’s experimental research; formulation-specific effects and irritation potential
That all rosemary-containing products cause hair loss
Calendula extract
Ingredient identity, botanical composition, allergy potential and experimental findings
That calendula in a commercial shampoo causes alopecia
Methylchloroisothiazolinone (MCI)
Documented contact-allergy potential
That every formula containing it causes scalp disease or hair loss
Methylisothiazolinone (MI)
Documented contact-allergy potential, particularly in sensitized people
That it directly causes follicular hair loss in all consumers
Polysorbate 60
Its role in the formula and its experimental effects in the FDA research
That it is a proven cause of human alopecia
Source: FDA’s final research report and its consumer guidance.
4.1 Methylisothiazolinone and methylchloroisothiazolinone: The allergy evidence
MI and MCI are preservatives that have been extensively investigated for their ability to cause allergic contact dermatitis.
Allergic contact dermatitis is an immune-mediated skin reaction that develops in a person who has become sensitized to a substance. Symptoms can include itching, redness, swelling, scaling, and sometimes blistering. When a reaction affects the scalp, the symptoms may be mistaken for dandruff or a general reaction to a hair product.
A 2021 analysis of North American Contact Dermatitis Group data covering 2001–2016 found that MI accounted for 9.7% of recorded positive patch-test reactions associated with hair-care products, while the MCI/MI combination accounted for 8.7%. These percentages describe the distribution of positive reactions in the study’s patch-tested population, not the risk among all shampoo users.
A separate peer-reviewed repeated-application study investigated MI in rinse-off products among people with established MI allergy. Its findings support the importance of considering exposure even when a product is designed to be rinsed off.
The distinction between allergic dermatitis and alopecia is critical. An allergic reaction can cause significant scalp inflammation, and severe or persistent inflammatory disease may complicate hair health. But the existence of an allergy study does not prove that MI directly causes permanent hair loss.
Furthermore, the current published ingredient list for DevaCurl Low-Poo Delight does not list MI or MCI. The FDA’s historical findings concerning ingredients shared by the tested WEN and DevaCurl products should not be generalized to the brand’s current formulas without verification.
4.2 Polysorbate 60: Why experimental findings require context
Polysorbate 60 is used in cosmetic formulations as an emulsifying or solubilizing ingredient. Its role in a product is different from that of a cleansing surfactant or a preservative.
It was one of the five ingredients evaluated in the FDA’s investigation. The report identified cellular effects under the experimental conditions, but it did not establish that Polysorbate 60 causes human alopecia at concentrations found in commercial products.
The correct follow-up questions would be:
What concentration was used in the laboratory experiments?
How does that concentration compare with the concentration in the finished product?
Was the substance applied to isolated cells, animal skin, or human scalp?
Were the exposure duration and conditions representative of ordinary use?
Have independent studies replicated the findings?
Without those answers, the presence of Polysorbate 60 should be documented as an ingredient overlap, not presented as proof of a toxic product.
4.3 Rosemary and calendula: Botanical does not mean risk-free
Rosemary and calendula are plant-derived ingredients, but botanical preparations can differ in composition depending on the species, extraction process, concentration, and formulation.
The FDA’s research gives us a reason to examine the exact preparations tested. It does not establish that every rosemary or calendula ingredient in every product is harmful.
For example, rosemary oil and rosemary extract are chemically different preparations. An ingredient list that identifies rosemary leaf oil cannot automatically be treated as equivalent to one identifying rosemary extract.
The same caution applies to calendula: a product containing a calendula extract should not be assumed to contain the identical material or concentration used in an experiment.
The scientific lesson is straightforward: the botanical source, preparation, dose, and finished formulation all matter.
5. Hair loss versus hair breakage: The distinction that changes the entire investigation
A major weakness in many viral discussions is that the word hair loss is used to describe several different problems.
A person may report that their hair is falling out when the actual issue is breakage along the hair shaft. Another person may have genuine shedding from the follicle, inflammatory scalp disease, traction alopecia, or a medical condition unrelated to shampoo.
The symptoms can look similar to consumers but have different causes.
A. Shedding from the follicle
Hair strands are released from follicles. Increased shedding can occur with conditions such as telogen effluvium, which may follow illness, stress, hormonal changes, nutritional problems, or other triggers. A shampoo cannot be assumed to be the cause simply because shedding occurred after the person started using it.
B. Hair-shaft breakage
Strands break at different points along their length. Dryness, friction, tangling, chemical processing, and grooming practices can contribute. Breakage may make hair appear thinner or prevent it from retaining length even when the follicles continue to produce hair.
C. Traction alopecia
Repeated pulling from tight braids, extensions, ponytails, buns, or other hairstyles can damage follicles. A peer-reviewed review by Billero and Miteva describes how the extent and duration of traction influence risk and why early recognition matters.
What does the peer-reviewed literature say?
The 2022 review Hair Cosmetics for the Hair Loss Patient explains that hair cosmetics can affect hair-fiber structure, remove lipids, and contribute to breakage or contact dermatitis when used improperly. It also emphasizes that hair-fiber integrity and follicular hair growth are different issues that clinicians need to evaluate separately.
An earlier review, Cosmetics and Hair Loss, published in 2002, argued that ordinary cosmetic hair-care products generally do not cause hair loss under normal use, while emphasizing the importance of considering hair biology and the history of cosmetic practices when investigating an individual case.
The existence of the FDA’s later WEN–DevaCurl research means that the subject deserves careful, product-specific investigation. It does not justify the opposite blanket claim that all shampoos cause alopecia.
The balanced conclusion is that hair-care products can contribute to certain adverse effects, including irritation and breakage, but the evidence for direct follicular hair loss must be established for the particular product, exposure, and outcome under investigation.
6. What this means for all 11 brands
The following assessment distinguishes what is currently established from what still requires product-specific research.
Brand
Priority for investigation
What remains to be verified
Kaleidoscope Hair Products
Specific shampoos, conditioners, scalp treatments and their claims
Current product-level ingredient lists and relevant evidence
Mielle Organics
Rosemary Mint Strengthening Shampoo; cleansing agents, botanical oils, preservatives and fragrance
Whether the specific formula is associated with documented adverse events or a demonstrated risk
Bask & Lather
Strengthen Hair Shampoo; surfactants, essential oils, preservatives and conditioning ingredients
Product-specific safety evidence and comparisons with other formulas
WEN Cosmetics
Historical Sweet Almond Mint Cleansing Conditioner
Historical formula, regulatory research, reported events and limitations of causation evidence
DevaCurl
Historical Low-Poo Delight and current cleanser formulas
Changes in formulas and whether findings concerning the historical product apply to any current version
SheaMoisture
Coconut & Hibiscus Curl & Shine Shampoo
Regional and historical formula differences and product-specific adverse effects
Camille Rose
Selected shampoo and conditioner formulas
Current ingredients, preservation system, fragrance and supporting efficacy evidence
TGIN
Selected shampoo and conditioner formulas
Current ingredients and evidence for any alleged adverse effects
As I Am
Coconut CoWash and selected cleansers
Current ingredient lists and comparisons with conventional shampoos
Aunt Jackie’s
Selected shampoo and conditioner formulas
Exact product labels, ingredients and evidence for any alleged risk
Carol’s Daughter
Selected cleansing and conditioning formulas
Exact formula history and product-specific safety evidence
The inclusion of a brand in this table is not an allegation of harm. WEN and DevaCurl have a specific regulatory research history relevant to this investigation; the other brands require separate, product-level evidence before any comparable conclusion can be drawn.
For each brand, a rigorous investigation should obtain the current package label, the manufacturer’s published ingredient list, and—where relevant historical labels. It should then compare those lists against credible scientific findings and regulatory records.
7. The overlooked issue: The same ingredient can behave differently in different formulas
One of the most important points in this investigation is that an ingredient list is not a complete safety assessment.
Consider three products that contain the same surfactant. One might combine it with conditioning agents and other surfactants designed to improve mildness. Another might have a different cleansing system, pH, viscosity, fragrance, and intended contact time.
Even if the ingredient names overlap, the products are not necessarily equivalent in performance or safety.
The 2015 review Hair Cosmetics: An Overview explains that shampoo formulations combine cleansing agents with ingredients that influence conditioning, manageability, and the physical behavior of the hair fiber. Inadequate formulation or inappropriate use can contribute to friction, tangling, and breakage.
A useful investigation must therefore examine the complete formula rather than count the number of ingredients that two products share.
Why the order of ingredients matters
In the United States, cosmetic ingredient labeling generally lists ingredients in
descending order of predominance, subject to labeling rules and exceptions for ingredients at concentrations of 1% or less and color additives.
The label does not usually disclose exact concentrations. Therefore, two ingredient lists cannot reliably establish whether the shared ingredient is present at the same concentration in both products.
This matters when interpreting laboratory research. If a substance produces an effect at a particular experimental concentration, that finding cannot automatically be applied to a finished shampoo without establishing whether the exposure is relevant.
Why rinse-off and leave in products must be evaluated separately
A shampoo that is rinsed off after a short period does not create the same exposure conditions as a scalp oil or leave-in treatment that remains on the skin for hours.
Exposure duration, frequency, application area, and individual sensitivity can affect the relevance of a potential hazard. Research involving rinse-off products and leave-in products should not be treated as interchangeable.
This is particularly important when examining essential oils, fragrance ingredients, and preservatives associated with contact allergy.
8. What evidence would establish that a product actually contributes to hair loss?
To move beyond speculation, the investigation needs evidence that connects the specific product to the specific outcome.
A scientifically useful evidence hierarchy looks like this:
Level 1: Verified ingredient overlap
The exact product labels confirm that two or more formulas share an ingredient. This establishes similarity, not harm.
Level 2: Laboratory evidence
Controlled experiments identify a plausible biological effect at a known exposure. This establishes a potential mechanism, not necessarily a real-world consumer risk.
Level 3: Clinical evidence
Human studies or appropriately conducted clinical investigations show a relationship between a defined exposure and a particular adverse outcome.
Level 4: Converging evidence of causation
Multiple lines of evidence support the connection, accounting for competing explanations, the product’s actual formula, dose, timing, and reproducibility.
The WEN–DevaCurl investigation illustrates why this distinction matters. The FDA documented abnormal hair-growth cycles in mice and identified ingredients that warranted further study, but it did not establish a firm causal link to human alopecia.
Similarly, a consumer reporting hair loss after using a shampoo provides a useful signal for investigation. The report does not independently prove causation, because hair loss can have many other explanations.
9. The strongest scientific conclusions from this investigation
The current evidence supports several conclusions.
First, shared ingredients are common across different hair-care brands. The verified examples in this investigation include CAPB across Mielle, Bask & Lather, and DevaCurl; sodium C14-16 olefin sulfonate across Mielle and Bask & Lather; and rosemary and coconut ingredients across Mielle and SheaMoisture.
These are documented similarities in selected products, not proof of a shared adverse effect.
Second, some ingredients have well-documented potential to cause specific adverse reactions. MI and MCI are relevant to contact-allergy research, while CAPB has also been investigated as a possible allergen. The likelihood of a reaction depends on the substance, formulation, exposure, and individual susceptibility.
Third, irritation and hair breakage should not automatically be described as alopecia. Peer-reviewed reviews of hair cosmetics describe ways in which cosmetic practices can damage the hair shaft, contribute to breakage, or cause contact dermatitis. These effects must be distinguished from follicular hair loss.
Fourth, the WEN/DevaCurl case deserves focused attention, but its findings have limits. The FDA’s experimental research identified a potential biological signal requiring further study; it did not prove that the five shared ingredients cause baldness in humans.
Fifth, there is not enough verified evidence in the current comparison to label all 11 brands unsafe or to conclude that their products cause hair loss. That determination would require more exact product labels, historical formula records, relevant adverse-event evidence, and product-specific safety data.
10. Final conclusion: Are natural hair products causing hair loss?
The scientifically defensible answer is that some hair-care products can contribute to adverse effects such as allergic contact dermatitis, irritation, or hair-fiber breakage. Whether a particular product causes follicular hair loss is a separate question that requires stronger, product-specific evidence.
The investigation of WEN and DevaCurl provides a concrete example of why shared ingredients deserve scrutiny. Yet the presence of a shared ingredient does not establish that two products have the same safety profile, and the FDA’s research did not prove that the products or their five shared ingredients cause human alopecia.
The comparison of Mielle Organics, Bask & Lather, DevaCurl, and SheaMoisture also demonstrates that botanical oils, conventional surfactants, conditioning agents, and preservatives can appear in products marketed with different formulations and claims. The relevant issue is not whether an ingredient sounds natural or synthetic, but whether the finished product is safe and effective under its intended conditions of use.
The next stage of this investigation should focus on obtaining and comparing the exact current and historical ingredient lists for all 11 brands, then matching those formulas against peer-reviewed research and regulatory evidence.
The objective should be transparency, not fear. Consumers deserve accurate ingredient information, credible research, and clear distinctions between established risks, possible mechanisms, and claims that remain unproven.
Scientific references and primary sources
The following peer-reviewed papers and regulatory documents provide the foundation for this article. The FDA report is a government research report, not itself a peer-reviewed journal article; it is identified separately for that reason.
Peer-reviewed research
1. Schnuch A, Lessmann H, Geier J, Uter W. (2011). “Is cocamidopropyl betaine a contact allergen? Analysis of network data and short review of the literature.” Contact Dermatitis, 64(4), 203–211. DOI: 10.1111/j.1600-0536.2010.01863.x. Read on PubMed.
2. Fowler JF Jr, Fowler LM, Hunter JE. (1997). “Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study.” Contact Dermatitis, 37(6), 276–281. DOI: 10.1111/j.1600-0536.1997.tb02464.x. Read on PubMed.
3. Warshaw EM et al. (2021). “Contact Dermatitis Associated With Hair Care Products: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001–2016.” Read on PubMed.
4. D’Souza P, Rathi SK. (2015). “Shampoos and Conditioners: What a Dermatologist Should Know?” More broadly, research on shampoo formulation and scalp effects is covered in the following review. Hair Cosmetics: An Overview, International Journal of Trichology (2015).
5. Gavazzoni Dias MFR. (2015). “Hair Cosmetics: An Overview.” International Journal of Trichology, 7(1), 2–15. Read the review.
6. Dias MFRG et al. (2022). “Hair Cosmetics for the Hair Loss Patient.” Read the full article.
7. Billero V, Miteva M. (2018). “Traction alopecia: the root of the problem.” Clinical, Cosmetic and Investigational Dermatology. Read on PubMed.
8. “Methylisothiazolinone in rinse-off products causes allergic contact dermatitis: a repeated open-application study.” (2015). Read on PubMed.
9. “Cosmetics and hair loss.” (2002). A review discussing the relationship between cosmetic hair care and hair-loss complaints. Read on PubMed.
Regulatory research
10. U.S. Food and Drug Administration. Studies on Hair Loss (Alopecia) Associated With Use of Cosmetic Hair Products and Ingredients in These Products. Final research report, project period August 31, 2018–August 30, 2022. Read the FDA report (PDF).
11. U.S. Food and Drug Administration. FDA Studies Possible Connection Between Hair Loss and Certain Hair Cleansing Products and Ingredients. Read the FDA’s explanation of the findings.
Manufacturer ingredient lists used in the comparison
Research limitation: This article establishes a preliminary comparison of selected formulas. It does not constitute a complete laboratory analysis or independent safety assessment of every product sold by all 11 brands. Published ingredient lists can change, and product labels should be checked before making brand-wide claims.
Comments